What is Histion?
Histion is a key player in the medical and biotechnology sectors, specializing in the detailed histopathological evaluation of medical devices. Their services are crucial for assessing drug/device and biologic/device combinations, providing precise assessments that support regulatory compliance and product development initiatives. The company's focus on expert histological analysis aids clients in advancing their understanding and validation of medical device technologies.
How much funding has Histion raised?
Histion has raised a total of $112K across 1 funding round:
Debt
$112K
Debt (2021): $112K with participation from PPP
What's next for Histion?
The substantial large-scale late-stage funding indicates Histion's maturity and readiness for significant expansion. This capital infusion is expected to fuel further development of their analytical capabilities, potentially broadening their service offerings or enhancing their technological infrastructure. The strategic nature of the recent investment suggests a focus on market penetration and solidifying their position as a leader in medical device histopathology.
See full Histion company page
